Fluvoxamine maleate
Fluvoxamine Maleate is a generic prescription medication, classified as a serotonin reuptake inhibitor, commonly used to treat obsessive-compulsive disorder, depression, and social anxiety. It comes in oral tablet form with strengths of 25 mg, 50 mg, and 100 mg, manufactured by Bionpharma Inc. under application ANDA217917. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Fluvoxamine Maleate is a generic prescription medication, classified as a serotonin reuptake inhibitor, commonly used to treat obsessive-compulsive disorder, depression, and social anxiety. It comes in oral tablet form with strengths of 25 mg, 50 mg, and 100 mg, manufactured by Bionpharma Inc. under application ANDA217917. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Fluvoxamine maleate",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Fluvoxamine maleate — ANDA 091476 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=091476"
}
]
|
| identifier | ANDA091476 |
| issued | 2016-09-16 |
| keyword |
[
"drug-information",
"health-care",
"medications",
"pharmaceuticals",
"public-health"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Fluvoxamine maleate |
